Godavari Biorefineries Ltd

- As of March 31, 2024, Godavari Biorefineries had consolidated borrowings of Rs. 663 crores. - The company recently completed an IPO to raise equity capital. - Rs. 240 crores from the IPO proceeds were allocated for full or partial repayment/prepayment of certain borrowings, aimed at reducing debt and interest costs. - The improved debt equity position is intended to free up internal accruals for business growth, especially in biobased chemicals. - There was no mention of new or upcoming fundraising through additional debt or equity beyond the completed IPO and debt repayment plans. - The focus appears to be on utilizing freed-up cash flow from debt reduction to finance expansion and CAPEX, including investments in grain-based ethanol capacity and biobased chemical capacity increases. In summary, no new fundraising through debt or equity is indicated beyond the recent IPO and planned debt repayment.

- The company plans to invest in expanding biobased specialty chemicals capacities, with some capacity increases expected from Q4 2025 onwards. - There is a strategic focus on developing a grain-based ethanol facility to add dual feedstock capability, providing flexibility and mitigating climate risk. - Current CAPEX for the grain-based ethanol project is under assessment, with a stronger update expected in the next quarter. - The IPO proceeds are being used primarily to reduce debt, thereby freeing up internal accruals and cash flow for these growth investments. - Investments will support participation in India’s ethanol blending program and biobased chemicals market, aligning with the company’s green energy transition strategy. - The company is investing in research and development, including in biobased chemicals and a cancer drug currently in safety trials.

- The company anticipates a better sugarcane crushing season from November 2024 to April 2025 due to favorable monsoon and restored ethanol blending program, leading to higher volumes and revenue in H2 FY25. - Revenue growth was 34% YoY in Q2 FY25 and 25% in H1 FY25 despite seasonality; a stronger performance and improved profitability are expected in H2 FY25 due to crushing season commencement. - Expansion plans include increasing capacities in biobased specialty chemicals starting Q4 2025, driven by strong global demand and co-creation with customers for decarbonization. - Investment in grain-based ethanol production will add dual feedstock flexibility, mitigate climate risks, and support growing ethanol blending mandates, potentially boosting volumes and sales. - Enhanced capacity utilization and debt reduction will free cash flow for growth investments, improving margins and scaling up specialty chemical offerings especially from 2025 onwards.

- Company expects significant improvement in H2 FY25 results due to commencement of sugarcane crushing from November 2024 and restoration of ethanol blending program, leading to higher production and revenue. - EBITDA and profitability traditionally stronger in H2; last 3 years showed H2 EBITDA over 100% of full-year EBITDA. - Investment focus on biobased chemicals expansion starting Q4 2025, aiming to improve segment profitability and ROCE. - Debt reduction via IPO proceeds will save approx. Rs. 24-25 crores annually in interest, freeing cash flow for growth investments. - Grain-based ethanol facility under planning, expected to give feedstock flexibility and mitigate climate risk, enhancing earnings stability. - Biobased specialty chemicals segment expected to see stronger demand and capacity ramp-up in H2 FY25, improving margins. - Overall, optimistic about improved profitability, cash flow, and sustained EPS growth in coming years aligned with expanding product portfolio and green transition.

- For ethanol bidding under government tenders, Godavari Biorefineries bid for over 10 crore liters but was allotted about 7.5 crore liters (5.4 crore liters for juice-based ethanol and 2.5 crore liters for B-heavy molasses). - No bids have been placed yet for grain-based ethanol as the company is still in the process of creating that capacity. - The company expects increased demand for biobased specialty chemicals in the second half of FY25, leading to capacity expansions starting Q4 FY25. - There is a strong funnel of product development projects with customers for biobased chemicals, with many early-stage molecules in development expected to mature over 3-4 years. - The crushing season for sugarcane has started recently, and full seasonal production will contribute positively to the order fulfillment and revenue in H2 FY25.